For overall breast cancer risk, there was no gene with a P-value that deviated from the null distribution (Fig 1A), but for ER-negative breast cancer risk analysis, there were several genes with P-values smaller than expected, including TP53INP2, HP, and DHODH (Fig 1B). This evidence concerns the gene HP and breast cancer.